The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Contraceptive Drugs and Devices Market Research Report 2025
Synopsis
A contraceptive is a device or drug that prevents a woman from becoming pregnant.
The global Contraceptive Drugs and Devices market was valued at US$ 6531.7 million in 2023 and is anticipated to reach US$ 8873.2 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Contraceptive Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptive Drugs and Devices.
Report Scope
The Contraceptive Drugs and Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptive Drugs and Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contraceptive Drugs and Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Segment by Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Segment by Application
Hospitals
Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contraceptive Drugs and Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A contraceptive is a device or drug that prevents a woman from becoming pregnant.
The global Contraceptive Drugs and Devices market was valued at US$ 6531.7 million in 2023 and is anticipated to reach US$ 8873.2 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Contraceptive Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptive Drugs and Devices.
Report Scope
The Contraceptive Drugs and Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptive Drugs and Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contraceptive Drugs and Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Segment by Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Segment by Application
Hospitals
Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Contraceptive Drugs and Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Contraceptive Drugs and Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Contraceptive Drugs and Devices Market Overview
1.1 Product Overview and Scope of Contraceptive Drugs and Devices
1.2 Contraceptive Drugs and Devices Segment by Type
1.2.1 Global Contraceptive Drugs and Devices Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Vaginal
1.2.4 Injectable Contraceptive Drugs
1.2.5 Male/Female Contraceptive Devices
1.3 Contraceptive Drugs and Devices Segment by Application
1.3.1 Global Contraceptive Drugs and Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Others
1.4 Global Contraceptive Drugs and Devices Market Size Estimates and Forecasts
1.4.1 Global Contraceptive Drugs and Devices Revenue 2019-2030
1.4.2 Global Contraceptive Drugs and Devices Sales 2019-2030
1.4.3 Global Contraceptive Drugs and Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Contraceptive Drugs and Devices Market Competition by Manufacturers
2.1 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Contraceptive Drugs and Devices Average Price by Manufacturers (2019-2024)
2.4 Global Contraceptive Drugs and Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contraceptive Drugs and Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contraceptive Drugs and Devices, Product Type & Application
2.7 Contraceptive Drugs and Devices Market Competitive Situation and Trends
2.7.1 Contraceptive Drugs and Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Contraceptive Drugs and Devices Players Market Share by Revenue
2.7.3 Global Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Contraceptive Drugs and Devices Retrospective Market Scenario by Region
3.1 Global Contraceptive Drugs and Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Contraceptive Drugs and Devices Global Contraceptive Drugs and Devices Sales by Region: 2019-2030
3.2.1 Global Contraceptive Drugs and Devices Sales by Region: 2019-2024
3.2.2 Global Contraceptive Drugs and Devices Sales by Region: 2025-2030
3.3 Global Contraceptive Drugs and Devices Global Contraceptive Drugs and Devices Revenue by Region: 2019-2030
3.3.1 Global Contraceptive Drugs and Devices Revenue by Region: 2019-2024
3.3.2 Global Contraceptive Drugs and Devices Revenue by Region: 2025-2030
3.4 North America Contraceptive Drugs and Devices Market Facts & Figures by Country
3.4.1 North America Contraceptive Drugs and Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Contraceptive Drugs and Devices Sales by Country (2019-2030)
3.4.3 North America Contraceptive Drugs and Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Contraceptive Drugs and Devices Market Facts & Figures by Country
3.5.1 Europe Contraceptive Drugs and Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Contraceptive Drugs and Devices Sales by Country (2019-2030)
3.5.3 Europe Contraceptive Drugs and Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptive Drugs and Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Contraceptive Drugs and Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Contraceptive Drugs and Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Contraceptive Drugs and Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Contraceptive Drugs and Devices Market Facts & Figures by Country
3.7.1 Latin America Contraceptive Drugs and Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Contraceptive Drugs and Devices Sales by Country (2019-2030)
3.7.3 Latin America Contraceptive Drugs and Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contraceptive Drugs and Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptive Drugs and Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Contraceptive Drugs and Devices Sales by Type (2019-2030)
4.1.1 Global Contraceptive Drugs and Devices Sales by Type (2019-2024)
4.1.2 Global Contraceptive Drugs and Devices Sales by Type (2025-2030)
4.1.3 Global Contraceptive Drugs and Devices Sales Market Share by Type (2019-2030)
4.2 Global Contraceptive Drugs and Devices Revenue by Type (2019-2030)
4.2.1 Global Contraceptive Drugs and Devices Revenue by Type (2019-2024)
4.2.2 Global Contraceptive Drugs and Devices Revenue by Type (2025-2030)
4.2.3 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2019-2030)
4.3 Global Contraceptive Drugs and Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Contraceptive Drugs and Devices Sales by Application (2019-2030)
5.1.1 Global Contraceptive Drugs and Devices Sales by Application (2019-2024)
5.1.2 Global Contraceptive Drugs and Devices Sales by Application (2025-2030)
5.1.3 Global Contraceptive Drugs and Devices Sales Market Share by Application (2019-2030)
5.2 Global Contraceptive Drugs and Devices Revenue by Application (2019-2030)
5.2.1 Global Contraceptive Drugs and Devices Revenue by Application (2019-2024)
5.2.2 Global Contraceptive Drugs and Devices Revenue by Application (2025-2030)
5.2.3 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2019-2030)
5.3 Global Contraceptive Drugs and Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Contraceptive Drugs and Devices Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Church & Dwight
6.3.1 Church & Dwight Corporation Information
6.3.2 Church & Dwight Description and Business Overview
6.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio
6.3.5 Church & Dwight Recent Developments/Updates
6.4 Warmer Chilcott
6.4.1 Warmer Chilcott Corporation Information
6.4.2 Warmer Chilcott Description and Business Overview
6.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio
6.4.5 Warmer Chilcott Recent Developments/Updates
6.5 Agile Therapeutics
6.5.1 Agile Therapeutics Corporation Information
6.5.2 Agile Therapeutics Description and Business Overview
6.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio
6.5.5 Agile Therapeutics Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Contraceptive Drugs and Devices Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 BioSante Pharmaceuticals
6.6.1 BioSante Pharmaceuticals Corporation Information
6.6.2 BioSante Pharmaceuticals Description and Business Overview
6.6.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio
6.7.5 BioSante Pharmaceuticals Recent Developments/Updates
6.8 Mayer Laboratories
6.8.1 Mayer Laboratories Corporation Information
6.8.2 Mayer Laboratories Description and Business Overview
6.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio
6.8.5 Mayer Laboratories Recent Developments/Updates
6.9 Pantarhei Bioscience
6.9.1 Pantarhei Bioscience Corporation Information
6.9.2 Pantarhei Bioscience Description and Business Overview
6.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio
6.9.5 Pantarhei Bioscience Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Corporation Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptive Drugs and Devices Industry Chain Analysis
7.2 Contraceptive Drugs and Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptive Drugs and Devices Production Mode & Process
7.4 Contraceptive Drugs and Devices Sales and Marketing
7.4.1 Contraceptive Drugs and Devices Sales Channels
7.4.2 Contraceptive Drugs and Devices Distributors
7.5 Contraceptive Drugs and Devices Customers
8 Contraceptive Drugs and Devices Market Dynamics
8.1 Contraceptive Drugs and Devices Industry Trends
8.2 Contraceptive Drugs and Devices Market Drivers
8.3 Contraceptive Drugs and Devices Market Challenges
8.4 Contraceptive Drugs and Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
